INTRODUCTION: Aggressive fibromatosis is a benign tumor, thought to arise from deep musculoaponeurotic structures, rarely found in the head or neck. However, when it does occur in the head and neck region, it tends to be more aggressive and associated with significant morbidity, which may be attributed to the vital vascular, neurological or anatomical structures in close proximity. CASE PRESENTATION: We report the case of a 39-year-old Pakistani man who presented with a two-month history of a lump on the right side of his neck. The mass was excised and histopathological analysis revealed a case of aggressive fibromatosis. CONCLUSION: Due to the rarity of the condition no guidelines are available on the indications and extent of each modality. Due to its aggressive behavior and tendency to invade local structures and recur, a multi-modality management strategy is usually employed. On the basis of this case, we suggest that aggressive surgery is a viable management option and may be successfully used as a single modality treatment.
INTRODUCTION:Aggressive fibromatosis is a benign tumor, thought to arise from deep musculoaponeurotic structures, rarely found in the head or neck. However, when it does occur in the head and neck region, it tends to be more aggressive and associated with significant morbidity, which may be attributed to the vital vascular, neurological or anatomical structures in close proximity. CASE PRESENTATION: We report the case of a 39-year-old Pakistani man who presented with a two-month history of a lump on the right side of his neck. The mass was excised and histopathological analysis revealed a case of aggressive fibromatosis. CONCLUSION: Due to the rarity of the condition no guidelines are available on the indications and extent of each modality. Due to its aggressive behavior and tendency to invade local structures and recur, a multi-modality management strategy is usually employed. On the basis of this case, we suggest that aggressive surgery is a viable management option and may be successfully used as a single modality treatment.
Authors: Rashmi Chugh; J Kyle Wathen; Shreyaskumar R Patel; Robert G Maki; Paul A Meyers; Scott M Schuetze; Dennis A Priebat; Dafydd G Thomas; Jon A Jacobson; Brian L Samuels; Robert S Benjamin; Laurence H Baker Journal: Clin Cancer Res Date: 2010-08-19 Impact factor: 12.531
Authors: M El-Haddad; M El-Sebaie; R Ahmad; E Khalil; M Shahin; R Pant; M Memon; A Al-Hebshi; Y Khafaga; M Al-Shabanah; A Allam Journal: Clin Oncol (R Coll Radiol) Date: 2009-10-28 Impact factor: 4.126